Should You Grab Influx Healthtech IPO at ₹91, 22% GMP? Detailed Review Inside | Influx Healthtech IPO Allotment |

Influx Healthtech IPO description – Influx Healthtech, a Mumbai-based company specializing in healthcare products, has established itself as a key player in contract manufacturing, serving as a third-party manufacturer. The company operates three manufacturing facilities in Thane, Maharashtra, with areas of approximately 6,500 square feet, 13,000 square feet, and 14,000 square feet. These plants are certified with GMP, HACCP, ISO 22000, and Halal standards, and are equipped with advanced machinery, a dedicated quality control department, and a skilled workforce.
The company specializes in several segments, including dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and homecare items. Additionally, Influx Healthcare produces active pharmaceutical ingredients (API) used in the formulation of tablets, capsules, and injectables.
Their client portfolio for the CDMO business includes prominent brands such as Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. For Fiscal Year 2024, the production capacities of Unit 1, Unit 2, and Unit 3 are 1,100 kg, 1,700 kg, and 7,300 kg, respectively. Influx Healthcare employs 165 permanent staff on payroll.

Promoters of Influx Healthtech – Mr. Munir Abdul Ganee Chandniwala, Ms. Shirin Munir Ahmed Chandniwala, and Mr. Abdul Ganee Abdul Rasul Chandniwala
Table of Contents
Influx Healthtech IPO Details
Influx Healthtech IPO Dates | 18 – 20 June 2025 |
Influx Healthtech Issue Price | INR 91 – 96 per share |
Fresh issue | 50,00,400 shares (INR 45.50 – 48 crore) |
Offer For Sale | 11,00,400 shares (INR 10.01 – 10.56 crore) |
Total IPO size | 61,00,800 shares (INR 55.52 – 58.57 crore) |
Minimum bid (lot size) | 1,200 shares (INR 1,15,200) |
Face Value | INR 10 per share |
Retail Allocation | 35% |
Listing On | NSE EMERGE |
Influx Healthtech Financial Performance
FY 2023 | FY 2024 | FY 2025 | |
Revenue | 76.06 | 99.97 | 104.85 |
Expenses | 66.32 | 85.08 | 87.11 |
Net income | 7.20 | 11.13 | 13.37 |
Influx Healthtech Offer News
- Influx Healthtech RHP
- Influx Healthtech Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2024
Influx Healthtech Valuations & Margins
FY 2023 | FY 2024 | FY 2025 | |
EPS | 3.96 | 6.13 | 7.36 |
PE ratio | – | – | 12.36 – 13.04 |
RONW (%) | 61.76 | 48.85 | 36.98 |
NAV | 6.42 | 12.55 | 19.91 |
ROCE (%) | 78.60 | 65.58 | 49.17 |
EBITDA (%) | 14.10 | 16.96 | 19.62 |
Debt/Equity | 0.07 | 0.01 | 0.01 |
Influx Healthtech IPO GMP Today
Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
24 June 2025 | 25 | – | 22,000 |
23 June 2025 | 25 | – | 22,000 |
21 June 2025 | 40 | – | 37,000 |
20 June 2025 | 40 | – | 37,000 |
19 June 2025 | 42 | – | 39,000 |
18 June 2025 | 38 | – | 35,000 |
17 June 2025 | 35 | – | 31,000 |
16 June 2025 | 21 | – | 20,000 |
14 June 2025 | 21 | – | 20,000 |
13 June 2025 | 17 | – | 16,000 |
Influx Healthtech IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division – INR 22.49 crore
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division – INR 11.49 crore
- Purchase of Machineries for Homecare and Cosmetic Division – INR 2.76 crore
- General Corporate Purpose
Influx Healthtech IPO Subscription – Live Updates
Category | QIB | NII | Retail | Total |
---|---|---|---|---|
Shares Offered | 11,59,200 | 8,70,000 | 20,29,200 | 40,58,400 |
20 Jun 2025 | 137.87 | 481.47 | 117.70 | 201.44 |
19 Jun 2025 | 1.69 | 32.58 | 35.73 | 25.33 |
18 Jun 2025 | 1.46 | 5.77 | 8.27 | 5.79 |
The market maker reservation portion of 3,06,000 shares and anchor investor portion of 17,36,400 shares are not included in the above calculations.
Influx Healthtech – Comparison With Listed Peers
Company | PE ratio | EPS | RONW (%) | Book Value | Revenue (Cr.) |
Influx Healthtech | 12.36 – 13.04 | 7.36 | 36.98 | 19.91 | 104.99 |
Sudarshan Pharma | 48.28 | 0.66 | 12.45 | 5.30 | 5,053.84 |
Quest Laboratories | 10.38 | 8.28 | 16.58 | 49.92 | 1,081.59 |
Influx Healthtech IPO Dates & Listing Performance
IPO Opening Date | 18 June 2025 |
IPO Closing Date | 20 June 2025 |
Finalization of Basis of Allotment | 23 June 2025 |
Initiation of refunds | 24 June 2025 |
Transfer of shares to demat accounts | 24 June 2025 |
IPO Listing Date | 25 June 2025 |
Opening Price on NSE SME | INR 132.50 per share (up 38.02%) |
Closing Price on NSE SME | INR 126.20 per share (up 31.46%) |
Influx Healthtech Offer Lead Manager
RAREVER FINANCIAL ADVISORS PRIVATE LIMITED
807, Iconic Shyamal, Shyamal Cross Road, 132 Ring Road,
Satellite, Manekbag, Ahmedabad, Gujarat, 380015 India
Phone: 079-4925 8260 / +91-99981 23745
Email: [email protected]
Website: www.rarever.in
Influx Healthtech Offer Registrar
MAASHITLA SECURITIES PRIVATE LIMITED
451, Krishna Apra Business Square,
Netaji Subhash Place, Pitampura, Delhi – 110034
Phone: +91-11-47581432
Email: [email protected]
Website: www.maashitla.com
Influx Healthtech Issue Contact Details
INFLUX HEALTHTECH LIMITED
109, Ghanshyam Enclave Premises,
Co-op Soc Plot No. 856, Laljipada, Kandivali West,
Mumbai 400067, Maharashtra, India
Phone: +91 7045997809
E-mail: [email protected]
Website: www.influxhealthtech.com
IPO FAQs
What is Influx Healthtech offer size?
Influx Healthtech offer size is INR 55.52 – 58.57 crores.
What is Influx Healthtech offer price band?
Influx Healthtech public offer price is INR 91 – 96 per share.
What is the lot size of Influx Healthtech IPO?
Influx Healthtech offer lot size is 1,200 shares.
What is Influx Healthtech IPO GMP today?
Influx Healthtech IPO GMP today is INR 25 per share.
What is Influx Healthtech kostak rate today?
Influx Healthtech kostak rate today is INR NA per application.
What is Influx Healthtech Subject to Sauda rate today?
Influx Healthtech’s Subject to Sauda rate today is INR 22,000 per application.